home / stock / rgnx / rgnx short
Short Information | REGENXBIO Inc. (NASDAQ:RGNX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,434,651 |
Total Actual Volume | 19,216,437 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 121,733 |
Average Short Percentage | 12.21% |
Is there a RGNX Short Squeeze or Breakout about to happen?
See the RGNX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-28-2024 | $22.33 | $21.07 | $22.42 | $20.94 | 486,968 | 45,423 | 9.33% |
03-27-2024 | $21.79 | $22.18 | $22.3838 | $21.4273 | 561,385 | 58,593 | 10.44% |
03-26-2024 | $21.88 | $21.67 | $22.31 | $21.47 | 345,696 | 52,100 | 15.07% |
03-25-2024 | $21.81 | $21.59 | $22.25 | $21.13 | 302,600 | 49,969 | 16.51% |
03-22-2024 | $22.49 | $21.78 | $22.84 | $21.75 | 279,146 | 39,929 | 14.3% |
03-21-2024 | $22.71 | $22.5 | $23.14 | $21.9601 | 713,092 | 61,548 | 8.63% |
03-20-2024 | $22.43 | $22.51 | $22.98 | $21.84 | 619,750 | 71,681 | 11.57% |
03-19-2024 | $22.26 | $22.39 | $22.96 | $21.99 | 768,874 | 92,150 | 11.99% |
03-18-2024 | $22.13 | $22.33 | $22.609 | $21.25 | 523,344 | 73,868 | 14.11% |
03-15-2024 | $21.73 | $22.19 | $22.84 | $21.73 | 1,373,469 | 74,091 | 5.39% |
03-14-2024 | $22.33 | $21.85 | $22.51 | $21.55 | 519,737 | 54,941 | 10.57% |
03-13-2024 | $21.93 | $22.47 | $23.07 | $21.9 | 518,724 | 58,494 | 11.28% |
03-12-2024 | $22.93 | $21.98 | $23.325 | $21.62 | 1,350,108 | 99,308 | 7.36% |
03-11-2024 | $22.91 | $22.85 | $23.565 | $22.55 | 675,641 | 78,331 | 11.59% |
03-08-2024 | $24.24 | $22.75 | $24.26 | $22.3001 | 1,559,938 | 197,832 | 12.68% |
03-07-2024 | $23.38 | $23.23 | $23.7 | $23 | 2,173,369 | 227,304 | 10.46% |
03-06-2024 | $26.74 | $24 | $27.16 | $23.24 | 1,235,289 | 155,470 | 12.59% |
03-05-2024 | $28.36 | $24.61 | $28.8 | $22.06 | 2,805,568 | 638,409 | 22.76% |
03-04-2024 | $21.64 | $21.36 | $21.785 | $20.125 | 895,357 | 160,845 | 17.96% |
03-01-2024 | $17.86 | $21.19 | $21.69 | $17.86 | 1,508,382 | 144,365 | 9.57% |
News, Short Squeeze, Breakout and More Instantly...
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD PR Newswire A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustain...
REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days PR Newswire ROCKVILLE, Md. , March 27, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Cantor Fitzgerald's Virtual DMD and Other Dystrop...
2024-03-13 08:00:00 ET Sarepta Therapeutics (NASDAQ: SRPT) could have a serious new competitor on the horizon. According to some fresh clinical data from Regenxbio (NASDAQ: RGNX) , another biotech, the company is making headway with a gene therapy for Duchenne muscular dystr...